Written Question·Department of Health and Social Care·UIN 18237

Futibatinib

Tabled: 5 December 2024

Answered: 11 December 2024

Named Day

Question

Mark Ferguson

To ask the Secretary of State for Health and Social Care, what funding is available for patients to receive the immunotherapy drug Futibatinib through the NHS; and what criteria his Department uses to determine whether a patient is eligible for any fundin

Answer

Karin Smyth

NHS England funds the use of licensed medicines that have been recommended by the National Institute for Health and Care Excellence (NICE). Futibatinib is licensed by the Medicines and Healthcare products Regulatory Agency and has been recommended by the ...

ⓘ

This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 18237) →